Anna Furgała

Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT1A receptor selective agonist, NLX-112 in mouse models of pain

Kinga Sałat, Marcin Kołaczkowski, Anna Furgała et al. · Neuropharmacology · 2017 · 49 citations · Full text

Pain Therapy, Health Sciences, Pain Medicine +12

Thiazoles with cyclopropyl fragment as antifungal, anticonvulsant, and anti-Toxoplasma gondii agents: synthesis, toxicity evaluation, and molecular docking study

Krzysztof Z. Łączkowski, Natalia Konklewska, Anna Biernasiuk et al. · Medicinal Chemistry Research · 2018 · 44 citations · Full text

Synthesis, antimicrobial and anticonvulsant screening of small library of tetrahydro-2<i>H</i>-thiopyran-4-yl based thiazoles and selenazoles

Krzysztof Z. Łączkowski, Anna Biernasiuk, Angelika Baranowska‐Łączkowska et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2016 · 40 citations · Full text

Antimicrobial Chemotherapy, Pharmaceutical Chemistry, Novel Thiazoles +19

Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain

Kinga Sałat, Anna Furgała, Robert Sałat · Inflammopharmacology · 2017 · 28 citations · Full text

Time-shifted co-administration of sub-analgesic doses of ambroxol and pregabalin attenuates oxaliplatin-induced cold allodynia in mice

Anna Furgała, Łukasz Fijałkowski, Alicja Nowaczyk et al. · Biomedicine & Pharmacotherapy · 2018 · 24 citations · Full text

Inflammation, Sub-analgesic Doses, Anti-inflammatory +12